Huseyin Naci

Huseyin Naci (M.H.S., Ph.D.) is an Associate Professor in the Department of Health Policy at the London School of Economics and Political Science (LSE) in the United Kingdom. He conducts research and teaches on health care policy and practice in Europe and the US with a focus on pharmaceuticals. Huseyin serves as the Program Director for LSE's Master’s in International Health Policy. He is also one of the Deputy Directors of LSE Health.

Huseyin’s research evaluates the quantity and quality of the evidence base underpinning the approval, adoption, reimbursement, and use of new pharmaceutical products in Europe and the US. His research has appeared in leading medical and health policy journals, including JAMA, The Lancet, The BMJ, Health Affairs, and The Milbank Quarterly. 

Huseyin has a Ph.D. from the Department of Social Policy at the LSE and a Master’s in Health Sciences from the Johns Hopkins Bloomberg School of Public Health. He was previously a Fellow in Pharmaceutical Policy Research (2012-13) and a Pyle Fellow in Population Medicine (2013-14) at the Harvard Medical School and Harvard Pilgrim Health Care Institute. In 2018-19, he was the recipient of the UK Harkness Fellowship in Health Care Policy and Practice, based at the Harvard Kennedy School of Government. Between 2020-2023, Huseyin was a member of the UK National Institute for Health and Care Excellence (NICE) Medical Technologies Advisory Committee. He currently serves as an Advisor to the Analysis section of The BMJ.